510(k) Report

510(k) · Cleared

Cleared

Modus Modular Distraction Osteogenesis System

K051946510(k) TraditionalCleared Aug 22, 200535-day reviewClass II21 CFR 872.4760

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Medartis, Inc. · MQN External Mandibular Fixator And/Or Distractor

Cleared on Aug 22, 2005 after a 35-day review. The FDA summary names no predicate by number. 1 later device descends from it.

Decided
Aug 22, 2005
Review
35 days
Class
Class II
Product code
MQN
Recalls
None
Predicates
0

1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 2008: 1 descendant cleared20052010201520202025
  1. This deviceK051946 Modus Modular Distraction Osteogenesis SystemMedartis, Inc. · 2005
  2. Descendant · cites it directly · 0 of its ownK080542 DistraxJohn W. King · 2008

Most influential descendants

Showing 1 of 1 · See all
  • K080542DistraxJohn W. King · 2008 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K051946Modus Modular Distraction Osteogenesis SystemMedartis, Inc.2005—
+1K080542DistraxJohn W. King2008—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200810
FIG. 1 — Lineage of K051946, 2005–2008Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MQN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MQN device

  1. #1 K220050 KLS Martin IPS Distractionscore 5.0 · 5 generations · no Class I recall
Get a 510(k) Report

What was it cleared against?

The FDA summary names no predicate by number.

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K080542DistraxJohn W. King20080

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K080542 (John W. King, 2008) has gone furthest, with 0 descendants of its own.

How does its category compare?

All MQN devices

MQN External Mandibular Fixator And/Or Distractor: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · MQN

1in 2022

2007: 42008: 32012: 12014: 12015: 12016: 12017: 12018: 12019: 12022: 1
2007high 4 (2007) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MQN

292in 2008

2007: 77 days median2008: 292 days median
2007high 292 (2008) · low 77 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MQN

1in 2014

2014: 1
2007high 1 (2014) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MQN

34in 2025

2007: 52008: 82009: 112010: 202011: 262012: 1072013: 1792014: 572015: 932016: 872017: 752018: 1082019: 1222020: 862021: 1012022: 612023: 392024: 602025: 34
2007high 179 (2013) · low 5 (2007)2025

MAUDE reports naming product code MQN, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200747705
2008329208
20090—011
20100—020
20110—026
20121—0107
20130—0179
20141—157
20151—093
20161—087
20171—075
20181—0108
20191—0122
20200—086
20210—0101
20221—061
20230—039
20240—060
20250—034
20260—0—

What is it indicated for?

The Modus® Modular Distraction Osteogenesis System is a subcutaneous distractor system intended for use in fractures, osteotomies and arthrodeses including: treatment of hemifacial microsomia, mandibular hypoplasia, microglossia, defects of the alveolar ridge, atrophic bone segments in the mandible and maxilla, mandibular symphysis widening, growth disturbances of the ascending corpus/ascending ramus, and LeFort I, and LeFort II/II advancements.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K051946: Modus Modular Distraction Osteogenesis System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K051946

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026